Scott Coker takes hard-line stance against PED users following Bellator 127 drug test fiasco

Four of the 22 mixed martial arts (MMA) fighters who competed at the Bellator 127 event, which took place back on Oct. 3, 2014, from inside the Pechanga Resort & Casino in Temecula, California, failed their post-fight drug tests, according to the California State Athletic Commission (CSAC).

And judging by today's press release, new CEO Scott Coker isn't too happy about it.

"I want to make very clear that under new management, Bellator will simply not stand for performance enhancing drugs inside our cage," Bellator President Scott Coker said. "We fully support the California State Athletic Commission in their process, and standby any disciplinary action handed out by Commissioner Andy Foster and the CSAC. Fans, media and our athletes need to have a clear understanding that drug use will simply not be tolerated by Bellator."

Coker also revealed that he recently tested Bellator 131 headliner Stephan Bonnar (results pending).

The fighters in question, Keith Berry, Nick Moghaddam, Rob Emerson, and Fernando Gonzalez, had urine samples tested by the UCLA Olympic lab, accredited by World Anti-Doping Agency (WADA). Outside of Berry, whose win was overturned to a No Contest, CSAC has yet to announce disciplinary action for the offending fighters.

Stay tuned.